Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases
Authors:
Open Access
- 27 February 2026
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (6) , 1875-1876
Abstract
No abstract availableKeywords
Funding Information
- Suzhou Municipal Science and Technology Bureau
- Ministry of Education of the People's Republic of China
- Hainan Provincial Health and Family Planning Commission
This publication has 5 references indexed in Scilit:
- Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for VitiligoNew England Journal of Medicine, 2022
- Vitiligo: A ReviewDermatology, 2020
- Quality of Life Impairment in Children and Adolescents with VitiligoPediatric Dermatology, 2013
- A review of the worldwide prevalence of vitiligo in children/adolescents and adultsInternational Journal of Dermatology, 2012
- The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task ForcePigment Cell Research, 2007